Efficacy and Safety Study of GED-0507-34-Levo for Treatment of UC
Public ClinicalTrials.gov record NCT02808390. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of GED-0507-34-Levo (GED0507) for Treatment of Subjects With Active Ulcerative Colitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of 2 doses of GED-0507-34-Levo in subjects with active, mild-to-moderate UC.
Study identification
- NCT ID
- NCT02808390
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 19 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 27, 2016
- Primary completion
- Jul 30, 2017
- Completion
- Jul 30, 2017
- Last update posted
- Nov 26, 2018
2016 – 2017
United States locations
- U.S. sites
- 11
- U.S. states
- 5
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Applications Laboratories, Inc. | San Diego | California | 92103 | — |
| Center for Advanced Gastroenterology, PLLC | Maitland | Florida | 32751 | — |
| Advanced Research Institute, Inc. | New Port Richey | Florida | 34653 | — |
| IMIC, Inc | Palmetto Bay | Florida | 33157 | — |
| BRCR Medical Center, Inc | Pembroke Pines | Florida | 33028 | — |
| Mount Sinai | New York | New York | 10029 | — |
| Penn State University Milton S. Hershey Medical Center | State College | Pennsylvania | 16803 | — |
| Texas Clinical Research Institute, LLC | Arlington | Texas | 76012 | — |
| Cook Children's Medical Center | Fort Worth | Texas | 76104 | — |
| Envision Clinical Research, LLC | Laredo | Texas | 78041 | — |
| Sagact, Pllc | San Antonio | Texas | 78212 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 49 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02808390, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 26, 2018 · Synced Sep 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02808390 live on ClinicalTrials.gov.